Cagrilintide

Core efficacy: Dual receptor activation, stronger appetite suppression & satiety prolongation; accelerate systemic fat breakdown, target abdominal/visceral fat, reduce fat percentage efficiently; no muscle loss, preserve lean body mass; slim face/waist/hip contour, tighten loose skin post fat loss; regulate glucose/lipid metabolism, improve insulin sensitivity, optimize metabolic disorder

Clinical application: Reconstitute with bacteriostatic water for subcutaneous injection; recommended dosage: 0.5mg once weekly (start), gradually up to 1-2mg/week, 8-12 weeks as a course

Storage: Lyophilized powder stored at 2-8℃ cool/dry/dark condition; reconstituted solution refrigerated, used up within 4 weeks, light protected

Safety & compliance: Mild occasional nausea/injection site redness (self-resolving with tolerance); professional clinical use only, strictly follow operation specs; forbidden for non-professional/self-use, pregnancy/lactation, severe gastrointestinal disease patients